Cryo Cell International (CCEL) Non Operating Investment Income (2019 - 2026)
Cryo Cell International (CCEL) reported Non Operating Investment Income of -$240458.0 for Q1 2026, down 665.77% year-over-year from $42501.4 in Q1 2025, and down 19.25% quarter-over-quarter from -$201648.0 in Q4 2025.
Cryo Cell International (CCEL) Non Operating Investment Income (2019 - 2026) Analysis & Trends
Cryo Cell International (CCEL) has 8 years of Non Operating Investment Income data on file, last reported at -$240458.0 in Q1 2026.
- Non Operating Investment Income for Q1 2026 came in at -$240458.0, down 665.77% year-over-year; the trailing twelve-month figure through Feb 2026 was -$1.0 million (down 231.92% YoY), and the FY2025 annual result was -$806267.0, down 174.93% from the prior year.
- Non Operating Investment Income retreated to -$240458.0 in Q1 2026 per CCEL's latest filing, from -$201648.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $522458.0 in Q3 2024 and troughed at -$379332.0 in Q2 2025.
- A 5-year average of $2419.5 and a median of -$8642.0 in 2022 frame the typical range for Non Operating Investment Income.
- The sharpest annual moves came in 2023 and 2024: Non Operating Investment Income plunged 9473.79% in 2023, then jumped 7570.01% in 2024.
- A 5-year view of Non Operating Investment Income shows it stood at -$515.0 in 2022, then sank by 9473.79% to -$49305.0 in 2023, then soared by 140.56% to $19999.0 in 2024, then slumped by 1108.29% to -$201648.0 in 2025, then slipped by 19.25% to -$240458.0 in 2026.
- Business Quant data shows CCEL's Non Operating Investment Income at -$240458.0 in Q1 2026, -$201648.0 in Q4 2025, and -$193886.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | - |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | - |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | - |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | - |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | - |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | - |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | - |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | - |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | - |
| 10 | Cryo Cell International | 29.64 Mn | 26.74 Mn | 6.03 Mn | -240,458.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -240,458.00 |
| Feb 28, 2026 | -240,458.00 |
| Nov 30, 2025 | -201,648.00 |
| Nov 30, 2025 | -201,648.00 |
| Aug 31, 2025 | -193,886.00 |
| Aug 31, 2025 | -193,886.00 |
| May 31, 2025 | -379,332.00 |
| May 31, 2025 | -379,332.00 |
| Feb 28, 2025 | -31,401.00 |
| Feb 28, 2025 | -31,401.00 |
| Nov 30, 2024 | 19,999.00 |
| Nov 30, 2024 | 19,999.00 |
| Aug 31, 2024 | 522,458.00 |
| Aug 31, 2024 | 522,458.00 |
| May 31, 2024 | 258,623.00 |
| May 31, 2024 | 258,623.00 |
| Feb 29, 2024 | 274,971.00 |
| Feb 29, 2024 | 274,971.00 |
| Nov 30, 2023 | -49,305.00 |
| Nov 30, 2023 | -49,305.00 |